Chinese Herbal Medicine for Gynecologic Patients

Summary

This is a prospective randomized-controlled trial looking at the safety and acceptability of using Chinese herbal medicine in patients with primary dysmenorrhea. The research team hopes to enroll 100 patients, 50 of whom will be randomized to receive the herbal tincture and 50 who will receive a placebo tincture. Patients will be enrolled and using the assigned tincture for twelve weeks. The research team will assess safety as a primary outcome by the presence or absence of adverse events related to study protocol during the period of participation.

Timeline

Start

2024-07

Primary completion

2024-07-16

Completion

2024-07-16

Outcome

Outcome not reported

Stopped: “Study withdrawn due to inability to determine path forward regarding study design between sponsor and institutional staff.”

Drugs

Indications